Journal of Clinical Haematology

Cesar Rodriguez

Hematology/Oncology

Icahn School of Medicine

USA

Academic Editor

Biography

Dr Cesar Rodriguez is an Associate Professor of Medicine at The Icahn School of Medicine and Clinical Director for Multiple Myeloma at Mount Sinai Hospital, Tisch Cancer Institute. Dr. Rodriguez received his medical degree in Monterrey, Mexico and completed training in Internal Medicine at Texas Tech University and a fellowship in Hematology/Oncology at the University of Louisville. He received transplant training at Seattle Cancer Care Alliance, Memorial Sloan Kettering, and Massachusetts General Hospital. He is part of the Wake Forest Institute of Regenerative Medicine, ASBMT Practice Guidelines Committee, BMT-CTN Myeloma Committee, Alliance Myeloma Committee, and the International Myeloma Working Group

Research Interest

Dr Rodriguez is a clinical and translational researcher with focus on early phase clinical trials on immunotherapy for myeloma and other plasma cell disorders. His laboratory focuses on 3-dimensional culture models and bioprinting to study the biology of myeloma cells and bone marrow microenvironment interactions that lead to drug resistance and tumor proliferation.